Corneal dystrophies
DR NAJARA THAPA
1ST YEAR RESIDENT
LEI, NAMS
Objective
 To understand different types of corneal dystrophy, their clinical features
and management.
2
Layout
 Introduction
 Classification
 Epithelial corneal dystrophies
 Corneal dystrophies of Bowmans layer
 Stromal corneal dystrophies
 Descemet membrane and endothelial dystrophies
3
History
 Gr. dys meaning ‘wrong’or ‘difficult’ ;and trophe meaning ‘nourishment’
 Introduced into the medical literature by Wilhelm Erb (1840–1921) in 1884
 Arthur Groenouw  Noduli Corneae (1890)
4
Introduction
 Non- inflammatory corneal opacifying disorders.
 Characteristic features:
 Usually have a strong pattern of inheritance
 Bilateral and symmetric
 Little to no relationship with systemic and environmental factors
 Begin early in life but clinically apparent later in life
 Slowly progressive
5
6
Features Degeneration Dystrophy
Onset Presents later in life,
associated with aging
Present early in life,
hereditary
Laterality Unilateral Bilateral; May
be asymmetric
Bilateral & symmetric
Family history Uncommon Common
Vascularization Common Uncommon
Location often peripherally
located
Centrally located
Progression Progression can be very
slow or rapid
Progression usually
slow
Classification: Based on anatomic location
 Epithelial and Subepithelial dystrophy
 Bowman layer dystrophy
 Stromal dystrophy
 Descemet membrane and Endothelial Dystrophy
7
According to anatomic level affected, genetic basis, clinical and
pathologic information, we have
International Committee for the Classification of Corneal Dystrophy
(IC3D)
8
9
EPITHELIAL AND SUBEPITHELIAL
DYSTROPHY
10
EPITHELIAL BASEMENT MEMBRANE DYSTROPHY
Syn. Map-dot fingerprint dystrophy or Cogan microcystic dystrophy or Anterior
basement membrane dystrophy
 Most common dystrophy
 Often sporadic; AD
 Genetics: locus 5q31, gene TGFB1 in minority
11
Clinical findings
 Women, age > 50
 Grey patches, fine lines and microcysts
 Best seen with retro- illumination, sclerotic scatter
 Recurrent epithelial erosions
 Transient blurred vision
 Can also cause irregular astigmatism and inaccurate IOL calculations
12
13
Geographic map likeFingerprint lines
HISTOPATHOLOGY:
 Thickening of basement membrane.
 Deposition of fibrillary protein between BM and basement
membrane
TREATMENT:
 5% NaCl drops or ointment
 Lubricating drops/ointment
 Debridement of the loosened epithelium
 Excimer laser phototherapeutic keratectomy (PTK)
14
MEESMAN EPITHELIAL DYSTROPHY
Syn. Juvenile hereditary epithelial dystrophy
 AD
 Slowly progressive (gene epithelial keratins; Locus 12q13)
SYMPTOMS:
 Asymptomatic
 Recurrent erosion and blurring (mild)
SIGNS:
 Myriad tiny intraepithelial cysts (centrally, extends to limbus)
 Whorled and wedge-shaped epithelial patterns
15
HISTOLOGY:
Irregular thickening of epithelial basement membrane and intra-
epithelial cysts (PAS positive).
 Intracytoplasmic ‘‘peculiar substance’’: focal collection of fibrogranular
material surrounded by tangles of cytoplasmic filaments (EM)
TREATMENT:
 Lubrication for minute erosions
 Soft contact lenses
16
LISCH EPITHELIAL CORNEAL DYSTROPHY
Syn. Band-shaped and whorled microcystic dystrophy
• X-linked dominant
• Onset- Childhood
Diffuse grayish epithelial opacities
Densely packed microcysts
17
Histology: Pronounced vacuolization of
epithelial cells
CORNEAL DYSTROPHIES OF
BOWMAN'S LAYER
18
REIS- BUCKLERS CORNEAL DYSTROPHY
 Syn. Corneal basement dystrophy type 1
 AD, TGFB1 gene
 Severe recurrent corneal erosion; visual impairment
19
HISTOLOGY:
 Replacement of corneal BM by connective tissue bands
 Eosinophilic and fibrotic material beneath the epithelium and in
anterior stroma
 Electron microscopic- rod shaped deposition
20
THIEL- BEHNKE CORNEAL DYSTROPHY
 Syn. Honeycomb shaped corneal dystrophy or corneal basement
dystrophy type 2; Waardenburg and Jonkers dystrophy
 Less severe than REIS-BUCKLERS
 AD; TGFB1 gene
 Recurrent erosions in childhood
21
HISTOPATHOLOGY:
 Wavy, sub-epithelial fibrosis with disruption of BM and of epithelial
basement membrane(saw tooth appearance).
Electron- microscopy:
 Curly collagen filaments replace the BM.
22
Treatment:
 T/t of recurrent erosion
 Superficial keratectomy; Excimer laser phototherapeutic
keratectomy
 Lamelar keratoplasty
 Penetrating keratoplasty
23
STROMAL DYSTROPHY
24
The Stromal Dystrophies 25
Granularcorneal dystrophy
Type 1 (classic) Type 2 (granular-lattice) Type 3 (Reis-Bücklers)
LATTICE corneal dystrophy MACULAR corneal dystrophy
CLASSIC FORM
GELSOLIN TYPE
GRANULAR CORNEAL DYSTROPHY (Type 1)
 AD
 Gene TGFB1; locus 5q31
 Deposition of small, discrete, sharply demarcated opacities
 Grayish-white opacities in the anterior central stroma
 Spare limbus
26
HISTOPATHOLOGY:
 Masson's trichrome stain: Eosinophilic, rod, or trapezoidal-
shaped hyaline deposits in the stroma
TREATMENT:
 PK / Deep lamellar keratoplasty
27
GRANULAR CORNEAL DYSTROPHY (Type 2)
Syn. Avellino corneal dystrophy; Combined granular-lattice dystrophy
 AD; gene TGFB1
 Recurrent erosions, visual impairment
(1) Anterior, stromal, discrete gray-white granular deposits
(2) Mid to posterior stromal lattice lesions
(3) Anterior stromal haze
28
HISTOLOGY:
 Hyaline(Masson trichrome) and amyloid (Congo Red)
29
treatment
Therapeutic contact lenses
Artificial tears
Epithelial erosions
SURGERY
Superficial
 Superficial keratectomy
 Lamellar keratoplasty
 Phototherapeutic keratectomy (PTK)
Deep  PK- recurrence as early as 1 year
30
MACULAR CORNEAL DYSTROPHY
 Inheritance: AR
 Genetcis: gene CHST6; locus: 16q22
Clinical findings:
 Least common
 Clear at birth and cloud between age 3-9 ( decrease vision
between 10-30)
 Focal gray- white opacities with indistinct edges
 Stroma between opacities is diffusely cloudy
31
Pathology:
 GAGs that stain with Alcian blue and colloidal iron
Treatment:
 Treat erosions
 PKP/ DALK
 Recurrence
32
Thick deposition of GAG
Diffuse deposition of GAG
33
treatment
Therapeutic contact lenses
Artificial tears
Epithelial erosions
SURGERY
 Superficial keratectomy
 Lamellar keratoplasty
 Phototherapeutic keratectomy (PTK)
 PK
34
 AD
 Bilateral
 Primary, localized corneal amyloidosis
35LATTICE DYSTROPHY
small refractile glass like filamentary lines
anterior stromal white dots
diffuse central anterior stromal haze
36
37
Characteristi
s
Lattice Type 1 Lattice Type 2 (Meretoja
syndrome)
Inheritance AD AD
Gene 5q31; TGFB1 9q34; gelsolin
Onset 10yrs 20-35yrs
Visual Acquity Poor after 40 Good until 65
Erosions Frequent Infrequent
Cornea Numerous glass like delicate
lines, amorphous deposits,
periphery clear
Few thick lines extend to
periphery, few amorphous
deposits
Systemic None Amyloidosis involving skin,
arteries and other organs
Face Normal Facial paresis, typical
dermatochalasis,
lagophthalmous,pedulous ears,
dry lax skin
Pathology
 Amyloid deposits concentrated in anterior stroma
 Stains pink with Congo red, metachromatically with
crystal violet, and exhibits birefringence with polarized
light
Management
 Patching, hypertonic agents, contact lens, superficial
keratectomy or PTK
 Severe cases with visual loss treated with DALK or PKP
 Recurrence is more common than other stromal
dystrophies
38
SCHNYDER CORNEAL DYSTROPHY
 Inheritance: AD
 Genetics: locus 1p36; gene UBIAD1
Clinical findings:
 Rare and slow progressive (predictable progression)
 Central opacification (20s);dense arcus (30s)
 Mid peripheral full thickness opacification (40s)
 Decreased corneal sensation
39
Pathology:
 Accumulations of cholesterol and phospholipids
 Oil-red- O stains the phospholipids red.
Management:
 Most have PKP by the age 50.
 Can recur
 Many have abnormal lipid panel
40
Polychromatic cholesterol crystals deposits-
geographic, annular, or disciform pattern
Treatment :
 Lipid profile
 PTK
 Lamellar keratoplasty
 PK
41
DESCEMET’S MEMBRANE AND
ENDOTHELIAL DYSTROPHY
42
FUCHS ENDOTHELIAL CORNEAL DYSTROPHY
Syn. Endoepithelial corneal dystrophy
 Inheritance: sporadic; occasional AD
 Gene locus: 13pTel –13q12.13, 15q, 18q21.2 –q21.32.
Early-onset variant:1p34.3 – p32 G
 Female preponderance
 Onset >50yrs (early onset variant-3rd decade)
43
Symptoms:
 Decrease in vision (edema)
 Pain (ruptured bullae); pain subsides once fibrosis
occurs
Clinical Findings:
 Corneal guttae (central to periphery)
 Decompensated cornea with stromal edema(DM folds)
 Epithelial edema, microcystic edema (epithelial bullae)
 Subepithelial fibrosis
44
stages
Stage 1: asymptomatic, central corneal guttae with fine pigment dusting,
vision and corneal thickness normal
Stage 2: Stromal edema, painless decreased vision glare and haloes
Stage 3: Persistent epithelial edema leading to microcysts and bullae pain
upon rupture
Stage 4 – Growth of avascular subepithelial connective tissue, scarring,
pain diminished but severely reduced vision
45
Pathogenesis:
Abnormal production of collagenous
material by the affected endothelial cells
Marked thickening of descemet’s membrane
guttae
Deposition of collagen and extracellular
matrix in Descemet’s membrane
Na+/K- pump
46
 Treatment:
- Reduce edema with NaCl drops
- Lower IOP
- Bandage Contact Lenses to protect exposed nerve
endings
- PK
47
POSTERIOR POLYMORPHOUS CORNEAL
DYSTROPHY
Syn. Posterior polymorphous dystrophy (PPMD); Schlichting dystrophy
 Inheritance: AD
 Unilateral
 Clinical features: (any or all of following)
 Isolated group vesicles
 Geographic-shaped, discrete, gray leisons
 Broad bands with scalloped edges
48
49
Pathogenesis:
- Focal metaplasia of endothelial cells into keratinized
epithelial-like cells.
- Loss of stromal deturgesence
- Tendency towards synechiae formation
Treatment:
Majority require no treatment
Keratoplasty for corneal opacification.
50
CONGENITAL HEREDITARY ENDOTHELIAL
DYSTROPHY
 AD/AR
 Onset is perinatal
 Focal or diffuse thickening of Descemet membrane and
endothelial degeneration
 Blue-gray with ground glass appearance to total
opacification
51
CHED 1 CHED 2
Autosomal dominant
(chr 20p11)
Autosomal recessive
(20p13)
Clear cornea at birth Corneal clouding at birth
Photophobia and epiphora
common
No Photophobia and epiphora
Vision better Vision poor
Nystagmus uncommon Nystagmus common
52
Diagnosing corneal dystrophies in the pediatric patient remains a challenge.
… take home messages…
 Inherited, bilateral and symmetric, slowly progressive
 Not related to environmental or systemic factors
 Early than degeneration (fuchs’ dystrophy which occurs in 40s-
50s)
 Positive family history
 Mostly autosomal dominant ( macular corneal dystrophy, CHAD 2-
AR)
 PPMD and fuchs’ dystrophy raised IOP
 Treatment- symptomatic. Surgery if vision impaired. Recurrence in
graft common
53
References
 AAO. External disease and cornea. 2013-2014
 Kanski. Clinical ophthalmology, 8th edition
 Jayne S et al. IC3D classification of corneal dystrophies- Edition-2. cornea.
Vol 32, feb 2015
 Yanoff and Ducker Ophthalmology, 3rd edition
 Internet sources, www.corneasociety.org
54
55
THANKYOU !!!

More Related Content

PPTX
Corneal Dystrophies
PPTX
Corneal dystrophy and degeneration
PPTX
MALARIA AND THE EYE
PPTX
Amblyopia
PPTX
Bullous keratopathy
PPTX
Entropion
PPTX
Corneal degeneration ppt
PPT
anatomy & physiology of lens
Corneal Dystrophies
Corneal dystrophy and degeneration
MALARIA AND THE EYE
Amblyopia
Bullous keratopathy
Entropion
Corneal degeneration ppt
anatomy & physiology of lens

What's hot (20)

PPTX
Pathological Myopia.pptx
PPTX
Macular hole
PPT
Age-Related Macular Degeneration
PDF
Visual Field in Glaucoma
PPT
Choroidal coloboma
PPTX
Vitreous
PPT
Tear film
PPTX
PPT
Cataract
PPTX
Anterior eye structures disorders
PPTX
Optics of human eye & refractive errors
PPT
Corneal Topography
PPTX
Central retinal vein occlusion CRVO
PPTX
Ectopia lentis edit
PPTX
Rhegmatogenous retinal detachment
PPTX
Anti vegf
PPTX
Vitreous substitutes
PPTX
Specular microscopy
PPTX
Immunosuppressive agents in ophthalmology
PPT
Biometry: Iol calculation
Pathological Myopia.pptx
Macular hole
Age-Related Macular Degeneration
Visual Field in Glaucoma
Choroidal coloboma
Vitreous
Tear film
Cataract
Anterior eye structures disorders
Optics of human eye & refractive errors
Corneal Topography
Central retinal vein occlusion CRVO
Ectopia lentis edit
Rhegmatogenous retinal detachment
Anti vegf
Vitreous substitutes
Specular microscopy
Immunosuppressive agents in ophthalmology
Biometry: Iol calculation
Ad

Similar to Corneal dystrophies (20)

PPTX
36 Corneal Dystrophies by Dr. Rahul.pptx
PPTX
CORNEAL DYSTROPHIES PRESENTATION IN OPTOMETRIST PERSPECTIVE
PPTX
Stromal and endothelial dystrophies ppt
PPTX
CORNEAL DYSTROPHIES AND DEGENERATIONS w IC3D classification.pptx
PPTX
CORNEAL DYSTROPHIES AND DEGENERATIONS with Latest IC3D update
PDF
cornealdystrophies-150324080331-conversion-gate01 (1)_copy_signed.pdf
PPTX
Corneal dystrophy ANJU.power point presentation
PPTX
corneal dystrophy.pptx
PPTX
Corneal Stromal and Endothelial Dystrophies.pptx
PPTX
Corneal dystrophy by_dr.adnan
PPT
Corneal dystrophies
PPTX
Presentation on CORNEAL DYSTROPHY PPT.pptx
PPTX
Corneal dystrophies
PPTX
CORNEAL DYSTROPHY, DEGENERATION and treatment
PPTX
corneal dystrophy and corneal disorders (1).pptx
PPTX
CORNEAL-DYSTROPHIES-Nafiz(2).pptx
PPTX
cornea.pptx
PPTX
Corneal Dystrophies
PPTX
CORNEAL DEGENERATION AND DYSTROPHIES.pptx
PPTX
CORNEAL_DYSTROPHIES_Autosaved_DHBbwn.pptx
36 Corneal Dystrophies by Dr. Rahul.pptx
CORNEAL DYSTROPHIES PRESENTATION IN OPTOMETRIST PERSPECTIVE
Stromal and endothelial dystrophies ppt
CORNEAL DYSTROPHIES AND DEGENERATIONS w IC3D classification.pptx
CORNEAL DYSTROPHIES AND DEGENERATIONS with Latest IC3D update
cornealdystrophies-150324080331-conversion-gate01 (1)_copy_signed.pdf
Corneal dystrophy ANJU.power point presentation
corneal dystrophy.pptx
Corneal Stromal and Endothelial Dystrophies.pptx
Corneal dystrophy by_dr.adnan
Corneal dystrophies
Presentation on CORNEAL DYSTROPHY PPT.pptx
Corneal dystrophies
CORNEAL DYSTROPHY, DEGENERATION and treatment
corneal dystrophy and corneal disorders (1).pptx
CORNEAL-DYSTROPHIES-Nafiz(2).pptx
cornea.pptx
Corneal Dystrophies
CORNEAL DEGENERATION AND DYSTROPHIES.pptx
CORNEAL_DYSTROPHIES_Autosaved_DHBbwn.pptx
Ad

Recently uploaded (20)

PPTX
A Detailed Physiology of Endocrine System.pptx
PPTX
SUMMARY OF EAR, NOSE AND THROAT DISORDERS INCLUDING DEFINITION, CAUSES, CLINI...
PPTX
Biostatistics Lecture Notes_Dadason.pptx
PPT
ANTI-HYPERTENSIVE PHARMACOLOGY Department.ppt
PPTX
Computed Tomography: Hardware and Instrumentation
PPTX
Introduction to CDC (1).pptx for health science students
PPTX
Nutrition needs in a Surgical Patient.pptx
PPTX
Acute Abdomen and its management updates.pptx
PPTX
ACUTE PANCREATITIS combined.pptx.pptx in kids
PPSX
Man & Medicine power point presentation for the first year MBBS students
PDF
Cranial nerve palsies (I-XII) - AMBOSS.pdf
PPTX
Approch to weakness &paralysis pateint.pptx
PDF
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
PPTX
Indications for Surgical Delivery...pptx
PDF
Demography and community health for healthcare.pdf
PPTX
IMMUNITY ... and basic concept mds 1st year
PDF
heliotherapy- types and advantages procedure
PDF
FMCG-October-2021........................
PDF
Diabetes mellitus - AMBOSS.pdf
PPTX
ANTI BIOTICS. SULPHONAMIDES,QUINOLONES.pptx
A Detailed Physiology of Endocrine System.pptx
SUMMARY OF EAR, NOSE AND THROAT DISORDERS INCLUDING DEFINITION, CAUSES, CLINI...
Biostatistics Lecture Notes_Dadason.pptx
ANTI-HYPERTENSIVE PHARMACOLOGY Department.ppt
Computed Tomography: Hardware and Instrumentation
Introduction to CDC (1).pptx for health science students
Nutrition needs in a Surgical Patient.pptx
Acute Abdomen and its management updates.pptx
ACUTE PANCREATITIS combined.pptx.pptx in kids
Man & Medicine power point presentation for the first year MBBS students
Cranial nerve palsies (I-XII) - AMBOSS.pdf
Approch to weakness &paralysis pateint.pptx
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
Indications for Surgical Delivery...pptx
Demography and community health for healthcare.pdf
IMMUNITY ... and basic concept mds 1st year
heliotherapy- types and advantages procedure
FMCG-October-2021........................
Diabetes mellitus - AMBOSS.pdf
ANTI BIOTICS. SULPHONAMIDES,QUINOLONES.pptx

Corneal dystrophies

  • 1. Corneal dystrophies DR NAJARA THAPA 1ST YEAR RESIDENT LEI, NAMS
  • 2. Objective  To understand different types of corneal dystrophy, their clinical features and management. 2
  • 3. Layout  Introduction  Classification  Epithelial corneal dystrophies  Corneal dystrophies of Bowmans layer  Stromal corneal dystrophies  Descemet membrane and endothelial dystrophies 3
  • 4. History  Gr. dys meaning ‘wrong’or ‘difficult’ ;and trophe meaning ‘nourishment’  Introduced into the medical literature by Wilhelm Erb (1840–1921) in 1884  Arthur Groenouw  Noduli Corneae (1890) 4
  • 5. Introduction  Non- inflammatory corneal opacifying disorders.  Characteristic features:  Usually have a strong pattern of inheritance  Bilateral and symmetric  Little to no relationship with systemic and environmental factors  Begin early in life but clinically apparent later in life  Slowly progressive 5
  • 6. 6 Features Degeneration Dystrophy Onset Presents later in life, associated with aging Present early in life, hereditary Laterality Unilateral Bilateral; May be asymmetric Bilateral & symmetric Family history Uncommon Common Vascularization Common Uncommon Location often peripherally located Centrally located Progression Progression can be very slow or rapid Progression usually slow
  • 7. Classification: Based on anatomic location  Epithelial and Subepithelial dystrophy  Bowman layer dystrophy  Stromal dystrophy  Descemet membrane and Endothelial Dystrophy 7
  • 8. According to anatomic level affected, genetic basis, clinical and pathologic information, we have International Committee for the Classification of Corneal Dystrophy (IC3D) 8
  • 9. 9
  • 11. EPITHELIAL BASEMENT MEMBRANE DYSTROPHY Syn. Map-dot fingerprint dystrophy or Cogan microcystic dystrophy or Anterior basement membrane dystrophy  Most common dystrophy  Often sporadic; AD  Genetics: locus 5q31, gene TGFB1 in minority 11
  • 12. Clinical findings  Women, age > 50  Grey patches, fine lines and microcysts  Best seen with retro- illumination, sclerotic scatter  Recurrent epithelial erosions  Transient blurred vision  Can also cause irregular astigmatism and inaccurate IOL calculations 12
  • 14. HISTOPATHOLOGY:  Thickening of basement membrane.  Deposition of fibrillary protein between BM and basement membrane TREATMENT:  5% NaCl drops or ointment  Lubricating drops/ointment  Debridement of the loosened epithelium  Excimer laser phototherapeutic keratectomy (PTK) 14
  • 15. MEESMAN EPITHELIAL DYSTROPHY Syn. Juvenile hereditary epithelial dystrophy  AD  Slowly progressive (gene epithelial keratins; Locus 12q13) SYMPTOMS:  Asymptomatic  Recurrent erosion and blurring (mild) SIGNS:  Myriad tiny intraepithelial cysts (centrally, extends to limbus)  Whorled and wedge-shaped epithelial patterns 15
  • 16. HISTOLOGY: Irregular thickening of epithelial basement membrane and intra- epithelial cysts (PAS positive).  Intracytoplasmic ‘‘peculiar substance’’: focal collection of fibrogranular material surrounded by tangles of cytoplasmic filaments (EM) TREATMENT:  Lubrication for minute erosions  Soft contact lenses 16
  • 17. LISCH EPITHELIAL CORNEAL DYSTROPHY Syn. Band-shaped and whorled microcystic dystrophy • X-linked dominant • Onset- Childhood Diffuse grayish epithelial opacities Densely packed microcysts 17 Histology: Pronounced vacuolization of epithelial cells
  • 19. REIS- BUCKLERS CORNEAL DYSTROPHY  Syn. Corneal basement dystrophy type 1  AD, TGFB1 gene  Severe recurrent corneal erosion; visual impairment 19
  • 20. HISTOLOGY:  Replacement of corneal BM by connective tissue bands  Eosinophilic and fibrotic material beneath the epithelium and in anterior stroma  Electron microscopic- rod shaped deposition 20
  • 21. THIEL- BEHNKE CORNEAL DYSTROPHY  Syn. Honeycomb shaped corneal dystrophy or corneal basement dystrophy type 2; Waardenburg and Jonkers dystrophy  Less severe than REIS-BUCKLERS  AD; TGFB1 gene  Recurrent erosions in childhood 21
  • 22. HISTOPATHOLOGY:  Wavy, sub-epithelial fibrosis with disruption of BM and of epithelial basement membrane(saw tooth appearance). Electron- microscopy:  Curly collagen filaments replace the BM. 22
  • 23. Treatment:  T/t of recurrent erosion  Superficial keratectomy; Excimer laser phototherapeutic keratectomy  Lamelar keratoplasty  Penetrating keratoplasty 23
  • 25. The Stromal Dystrophies 25 Granularcorneal dystrophy Type 1 (classic) Type 2 (granular-lattice) Type 3 (Reis-Bücklers) LATTICE corneal dystrophy MACULAR corneal dystrophy CLASSIC FORM GELSOLIN TYPE
  • 26. GRANULAR CORNEAL DYSTROPHY (Type 1)  AD  Gene TGFB1; locus 5q31  Deposition of small, discrete, sharply demarcated opacities  Grayish-white opacities in the anterior central stroma  Spare limbus 26
  • 27. HISTOPATHOLOGY:  Masson's trichrome stain: Eosinophilic, rod, or trapezoidal- shaped hyaline deposits in the stroma TREATMENT:  PK / Deep lamellar keratoplasty 27
  • 28. GRANULAR CORNEAL DYSTROPHY (Type 2) Syn. Avellino corneal dystrophy; Combined granular-lattice dystrophy  AD; gene TGFB1  Recurrent erosions, visual impairment (1) Anterior, stromal, discrete gray-white granular deposits (2) Mid to posterior stromal lattice lesions (3) Anterior stromal haze 28
  • 29. HISTOLOGY:  Hyaline(Masson trichrome) and amyloid (Congo Red) 29
  • 30. treatment Therapeutic contact lenses Artificial tears Epithelial erosions SURGERY Superficial  Superficial keratectomy  Lamellar keratoplasty  Phototherapeutic keratectomy (PTK) Deep  PK- recurrence as early as 1 year 30
  • 31. MACULAR CORNEAL DYSTROPHY  Inheritance: AR  Genetcis: gene CHST6; locus: 16q22 Clinical findings:  Least common  Clear at birth and cloud between age 3-9 ( decrease vision between 10-30)  Focal gray- white opacities with indistinct edges  Stroma between opacities is diffusely cloudy 31
  • 32. Pathology:  GAGs that stain with Alcian blue and colloidal iron Treatment:  Treat erosions  PKP/ DALK  Recurrence 32 Thick deposition of GAG Diffuse deposition of GAG
  • 33. 33
  • 34. treatment Therapeutic contact lenses Artificial tears Epithelial erosions SURGERY  Superficial keratectomy  Lamellar keratoplasty  Phototherapeutic keratectomy (PTK)  PK 34
  • 35.  AD  Bilateral  Primary, localized corneal amyloidosis 35LATTICE DYSTROPHY small refractile glass like filamentary lines
  • 36. anterior stromal white dots diffuse central anterior stromal haze 36
  • 37. 37 Characteristi s Lattice Type 1 Lattice Type 2 (Meretoja syndrome) Inheritance AD AD Gene 5q31; TGFB1 9q34; gelsolin Onset 10yrs 20-35yrs Visual Acquity Poor after 40 Good until 65 Erosions Frequent Infrequent Cornea Numerous glass like delicate lines, amorphous deposits, periphery clear Few thick lines extend to periphery, few amorphous deposits Systemic None Amyloidosis involving skin, arteries and other organs Face Normal Facial paresis, typical dermatochalasis, lagophthalmous,pedulous ears, dry lax skin
  • 38. Pathology  Amyloid deposits concentrated in anterior stroma  Stains pink with Congo red, metachromatically with crystal violet, and exhibits birefringence with polarized light Management  Patching, hypertonic agents, contact lens, superficial keratectomy or PTK  Severe cases with visual loss treated with DALK or PKP  Recurrence is more common than other stromal dystrophies 38
  • 39. SCHNYDER CORNEAL DYSTROPHY  Inheritance: AD  Genetics: locus 1p36; gene UBIAD1 Clinical findings:  Rare and slow progressive (predictable progression)  Central opacification (20s);dense arcus (30s)  Mid peripheral full thickness opacification (40s)  Decreased corneal sensation 39
  • 40. Pathology:  Accumulations of cholesterol and phospholipids  Oil-red- O stains the phospholipids red. Management:  Most have PKP by the age 50.  Can recur  Many have abnormal lipid panel 40 Polychromatic cholesterol crystals deposits- geographic, annular, or disciform pattern
  • 41. Treatment :  Lipid profile  PTK  Lamellar keratoplasty  PK 41
  • 43. FUCHS ENDOTHELIAL CORNEAL DYSTROPHY Syn. Endoepithelial corneal dystrophy  Inheritance: sporadic; occasional AD  Gene locus: 13pTel –13q12.13, 15q, 18q21.2 –q21.32. Early-onset variant:1p34.3 – p32 G  Female preponderance  Onset >50yrs (early onset variant-3rd decade) 43
  • 44. Symptoms:  Decrease in vision (edema)  Pain (ruptured bullae); pain subsides once fibrosis occurs Clinical Findings:  Corneal guttae (central to periphery)  Decompensated cornea with stromal edema(DM folds)  Epithelial edema, microcystic edema (epithelial bullae)  Subepithelial fibrosis 44
  • 45. stages Stage 1: asymptomatic, central corneal guttae with fine pigment dusting, vision and corneal thickness normal Stage 2: Stromal edema, painless decreased vision glare and haloes Stage 3: Persistent epithelial edema leading to microcysts and bullae pain upon rupture Stage 4 – Growth of avascular subepithelial connective tissue, scarring, pain diminished but severely reduced vision 45
  • 46. Pathogenesis: Abnormal production of collagenous material by the affected endothelial cells Marked thickening of descemet’s membrane guttae Deposition of collagen and extracellular matrix in Descemet’s membrane Na+/K- pump 46
  • 47.  Treatment: - Reduce edema with NaCl drops - Lower IOP - Bandage Contact Lenses to protect exposed nerve endings - PK 47
  • 48. POSTERIOR POLYMORPHOUS CORNEAL DYSTROPHY Syn. Posterior polymorphous dystrophy (PPMD); Schlichting dystrophy  Inheritance: AD  Unilateral  Clinical features: (any or all of following)  Isolated group vesicles  Geographic-shaped, discrete, gray leisons  Broad bands with scalloped edges 48
  • 49. 49
  • 50. Pathogenesis: - Focal metaplasia of endothelial cells into keratinized epithelial-like cells. - Loss of stromal deturgesence - Tendency towards synechiae formation Treatment: Majority require no treatment Keratoplasty for corneal opacification. 50
  • 51. CONGENITAL HEREDITARY ENDOTHELIAL DYSTROPHY  AD/AR  Onset is perinatal  Focal or diffuse thickening of Descemet membrane and endothelial degeneration  Blue-gray with ground glass appearance to total opacification 51
  • 52. CHED 1 CHED 2 Autosomal dominant (chr 20p11) Autosomal recessive (20p13) Clear cornea at birth Corneal clouding at birth Photophobia and epiphora common No Photophobia and epiphora Vision better Vision poor Nystagmus uncommon Nystagmus common 52 Diagnosing corneal dystrophies in the pediatric patient remains a challenge.
  • 53. … take home messages…  Inherited, bilateral and symmetric, slowly progressive  Not related to environmental or systemic factors  Early than degeneration (fuchs’ dystrophy which occurs in 40s- 50s)  Positive family history  Mostly autosomal dominant ( macular corneal dystrophy, CHAD 2- AR)  PPMD and fuchs’ dystrophy raised IOP  Treatment- symptomatic. Surgery if vision impaired. Recurrence in graft common 53
  • 54. References  AAO. External disease and cornea. 2013-2014  Kanski. Clinical ophthalmology, 8th edition  Jayne S et al. IC3D classification of corneal dystrophies- Edition-2. cornea. Vol 32, feb 2015  Yanoff and Ducker Ophthalmology, 3rd edition  Internet sources, www.corneasociety.org 54

Editor's Notes

  • #5: the term is most commonly used to describe an inherited disorder affecting cells, tissues, or organs, alone or in combination. Arthur Groenouw (1862–1945) published his classic paper describing 2 patients with ‘‘noduli corneae,’’ with 1 patient having granular corneal dystrophy and the other, macular corneal dystrophy.
  • #6: exceptions to each of these definitions have been noted. patients with epithelial basement membrane dystrophy: no hereditary pattern. patients with posterior polymorphous corneal dystrophy manifest unilaterally. In macular dystrophy, the level of antigenic serum keratan sulfate correlates with the immunophenotypes of the disease, indicating that systemic abnormalities are integral to the development of the characteristic corneal changes.
  • #12: The most common dystrophy seen in clinical practice; Onset in the 2nd decade
  • #13: Signs: lesions besat visualized in retroillumination Dot like and microcystic epithelial lesion; subepithelial map laike pattern; whorled fingerprint like lines; bleb like subepithelial pebbled glass pattern
  • #14: Thin, relucent hair like lines (fingerprint) thicker irregular surrounded by fine haze (map like) Dot like and microcystic epithelial lesion; subepithelial map laike pattern; whorled fingerprint like lines; bleb like subepithelial pebbled glass pattern
  • #15: Extra sheets of basement membrane material grow into the epithelium. Masson trichrome; F, PAS,
  • #16: It has been linked to mutations in corneal keratin (K3 and K12) that are specifically expressed in the epithelium and not in other layers.
  • #17: EM: ELECTRON MICROSCO Degenerated epithelial cell products with cytoplasmic and nuclear debris
  • #20: Confluent irregular and coarse geographic opacities with varying densities at Bowman layer and superficial stroma
  • #21: Masson trichrome stains keratohyalin intensely red beneath the epithelium and between superficial stromal lamellae. Note characteristic destruction of the Bowman layer
  • #22: Symmetric subepithelial reticular opacities sparing peripheral cornea (thus the name honeycomb)
  • #23: There is varying thickness of the epithelium due to a thickened abnormal subepithelial fibrous layer (arrowheads) that replaces the Bowman layer and has a characteristic sawtooth-like surface
  • #27: Crumb like opacities in the superficial cornea. On direct illumination, it appears white, indirect illumitnation, it appears small translucent dots with vacuoles (crushed bread crumb appearance) Drop-shaped; Crumb-shaped; Ringshaped
  • #28: Noncollagenous protein derived from keratocytes
  • #29: Stellate shaped snowflake like opacities Fine superficial opacities, stellate or annular lesions
  • #30: Dashes in GCD2 appear whiter, and lattice lines in LCD are more refractile. 2. Dashes in GCD2 rarely cross each other, while lattice lines in LCD characteristically intersect to result in the pathognomonic lattice configuration.
  • #31: TREATMENT: Lamellar Keratoplasty or PK (PTK is not recommended as it results in increased opacification)
  • #32: Involves entire stroma and periphery Carbohydrate sulfotransferase 6
  • #33: Colloidal iron stain
  • #36: Congo red stain
  • #39: This same section viewed with polarized light confirms deposits are birefringent
  • #40: Disproportionately reduces photopic vision with excellent scotopic vision UbiA prenyltransferase domain containing protein
  • #41: Oil Red O stains innumerable tiny lipid droplets within the corneal stroma in a frozen section Sine crystals
  • #45: Corneal thickness increases to nearly 1mm (normal is 0.52-0.56mm) Symptoms worsens upon awakening because of the decreased surface evaporation during sleep
  • #46: Stage 1 at this stage patients vision is nrmal; stroma n epithelium uninvolved
  • #47: Guttae, Latin for "drops," are excrescences of collagen produced by stressed corneal endothelial cells. 
  • #49: this rare dystrophy has a clinical spectrum that ranges from congenital corneal edema to late-onset corneal edema in middle age. Many cases are subclinical and have good vision Broad peripheral synechia Increased intraocular pressure Iris atrophy/corectopia
  • #50: Pic1: isolated vesicles bilaterally, which appear as circular or oval transparent cysts with a gray halo at the level of Descemet’s membrane, best viewed by retroillumination Pic2: band-shaped or “snail track” areas, which typically have scalloped edges Pic3: rounded dark area with central cell detail (doughnut like pattern)
  • #52: other features: corneal thickness two to three times normal (>1mm centrally), normal IOP, and normal corneal diameter. Associated features are corneal pannus, nystagmus, and esotropia.
  • #53: t/t: these patients require keratoplasty due to the bilateral nature of the corneal edema. despite significant corneal haze and absence of a red reflex, patients often seem to see much better than expected.